16683002: Progesterone (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Hormone\...

\Sex hormone (substance)\Progesterone receptor agonist\Progesterone

\Steroid hormone\Progesterone

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid (substance)\...

\Pregnane (substance)\Progesterone

\Steroid hormone\Progesterone

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

28249012 Progesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

743753010 Progesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2652031000005116 Progesteron da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Progesterone	Is a	Ovariehormon	false	Inferred relationship	Some
Progesterone	Is a	Progestationelt hormon	false	Inferred relationship	Some
Progesterone	Is a	Progesteronderivat	false	Inferred relationship	Some
Progesterone	Is a	Pregnane (substance)	true	Inferred relationship	Some
Progesterone	Is a	Steroid hormone	true	Inferred relationship	Some
Progesterone	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Progestational hormone	false	Inferred relationship	Some
Progesterone	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Ovarian hormone	false	Inferred relationship	Some
Progesterone	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Progesterone receptor agonist (disposition)	true	Inferred relationship	Some
Progesterone	Is a	Progesterone receptor agonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Megestrol	Is a	False	Progesterone	Inferred relationship	Some
Dydrogesterone (substance)	Is a	False	Progesterone	Inferred relationship	Some
Ethisterone	Is a	False	Progesterone	Inferred relationship	Some
Norethisterone	Is a	False	Progesterone	Inferred relationship	Some
Etynodiol diacetate	Is a	False	Progesterone	Inferred relationship	Some
Norgestrel	Is a	False	Progesterone	Inferred relationship	Some
Noretynodrel	Is a	False	Progesterone	Inferred relationship	Some
Desogestrel	Is a	False	Progesterone	Inferred relationship	Some
Hydroxyprogesterone (substance)	Is a	False	Progesterone	Inferred relationship	Some
Medroxyprogesterone	Is a	False	Progesterone	Inferred relationship	Some
Flurogestone acetate	Is a	False	Progesterone	Inferred relationship	Some
Norgestimate	Is a	False	Progesterone	Inferred relationship	Some
Delmadinone acetate (substance)	Is a	False	Progesterone	Inferred relationship	Some
Cortodoxone (substance)	Is a	False	Progesterone	Inferred relationship	Some
20-hydroxyprogesterone (substance)	Is a	False	Progesterone	Inferred relationship	Some
17-hydroxyprogesteron	Is a	False	Progesterone	Inferred relationship	Some
Progesterone/estradiol ratio measurement	Has measured component	False	Progesterone	Inferred relationship	Some
Progesterone adverse reaction	Causative agent	True	Progesterone	Inferred relationship	Some	1
Progesterone measurement	Has measured component	False	Progesterone	Inferred relationship	Some
Serum progesterone measurement	Has measured component	False	Progesterone	Inferred relationship	Some
Radiobioassay - progesterone (procedure)	Component	True	Progesterone	Inferred relationship	Some	1
Progesterone/estradiol ratio measurement	Component	True	Progesterone	Inferred relationship	Some	1
Progesterone measurement	Component	True	Progesterone	Inferred relationship	Some	1
Serum progesterone measurement	Component	False	Progesterone	Inferred relationship	Some	2
Allergy to progesterone	Causative agent	False	Progesterone	Inferred relationship	Some
progesteron 50 mg/ml injektionsvæske, opløsning, ampul a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Progesterone 40 mg/g vaginal gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Progesterone 80 mg/g vaginal gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
progesteron 200 mg vagitorium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
progesteron 400 mg vagitorium	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
progesteron 50 mg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing progesterone in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Progesterone	Inferred relationship	Some	1
progesteron til rektal/vaginal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Progesterone 200 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Progesterone 100mg softgels (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
progesteron 50 mg/ml olie	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Progesterone 90mg gel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Progesterone 50mg/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Norelgestromin (substance)	Is a	False	Progesterone	Inferred relationship	Some
Gestodene (substance)	Is a	False	Progesterone	Inferred relationship	Some
Gestonorone (substance)	Is a	False	Progesterone	Inferred relationship	Some
Product containing progesterone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Progesterone	Inferred relationship	Some	1
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Estradiol valerate 2 mg and norethisterone 700 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Desogestrel 150 microgram and ethinylestradiol 20 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing precisely desogestrel 150 microgram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
ethinylestradiol 35 µg + norethisteron 1 mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
ethinylestradiol + gestoden + placebo /75 µg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
ethinylestradiol 20 µg + progestogen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
ethinylestradiol 30 µg + progestogen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Ethinylestradiol 35mcg+progestogen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
ethinylestradiol 50 µg + progestogen	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
kombinationspræparat med østrogen og progestin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Combined oestogen+progestogen preparations	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Menstrual disorder comb.preps	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Progesterone - only contraceptives	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
levonorgestrel 125 µg/ethinylestradiol 30 µg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
levonorgestrel 50 µg/ethinylestradiol 30 µg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
levonorgestrel 75 µg/ethinylestradiol 40 µg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Drospirenone (substance)	Is a	False	Progesterone	Inferred relationship	Some
progesteron 50 mg/ml injektionsvæske, opløsning, hætteglas a 10 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
progesteron 20 mg creme til topikal anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Ethynodiol diacetate preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing norgestimate (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing desogestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
accidentel forgiftning med kombineret østrogen og progesteron	Causative agent	False	Progesterone	Inferred relationship	Some	2
tilsigtet forgiftning med kombineret østrogen og progesteron	Causative agent	False	Progesterone	Inferred relationship	Some	1
forgiftning med kombineret østrogen og progesteron, uvist med hvilken hensigt	Causative agent	False	Progesterone	Inferred relationship	Some	2
bivirkning af østrogen- og progestogenpræparat	Causative agent	False	Progesterone	Inferred relationship	Some	1
allergi over for østrogen og progestogen	Causative agent	False	Progesterone	Inferred relationship	Some
Product containing allylestrenol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Dydrogesterone 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
hydroxyprogesteroncaproat 250 mg/ml injektionsvæske, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Medroxyprogesterone acetate 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Medroxyprogesterone acetate 2.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Medroxyprogesterone acetate 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Norethisterone 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Norethisterone 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing lynestrenol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Mestranol 50 microgram and norethisterone 1 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing precisely etynodiol diacetate 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
medroxyprogesteronacetat 150 mg/ml injektionsvæske, suspension i fyldt injektionssprøjte a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
norethisteronenanthat 200 mg/ml injektionsvæske, opløsning, ampul a 1 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Product containing etonogestrel (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
etonogestrel 68 mg implantat til subkutan anvendelse	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
gestronolhexanoat 100 mg/ml injektionsvæske, opløsning, ampul a 2 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Medroxyprogesterone acetate 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some
Medroxyprogesterone acetate 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Progesterone	Inferred relationship	Some

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
28249012	Progesterone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
743753010	Progesterone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2652031000005116	Progesteron	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)